combretastatin has been researched along with triazoles in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Baraldi, PG; Basso, G; Bortolozzi, R; Brancale, A; Carrion, MD; Chen, L; Cruz-Lopez, O; Hamel, E; Lopez Cara, C; Romagnoli, R; Viola, G | 1 |
| Aziz, G; Hansen, TV; Mathisen, GH; Odlo, K; Paulsen, RE | 1 |
| Blokhin, DY; Chekhun, VF; Chernysheva, NB; Demchuk, DV; Firgang, SI; Kiselyov, AS; Konyushkin, LD; Kuiava, LM; Philchenkov, AA; Raihstat, MM; Samet, AV; Semenov, VV; Semenova, MN; Stashina, GA; Ushkarov, VI; Zavelevich, MP | 1 |
| Kamal, A; Kapure, JS; Nagaraju, B; Nayak, VL; Prasad, B; Shaheer Malik, M; Shaik, B; Shaik, TB | 1 |
| Alberto Marco, J; Carda, M; Díaz-Oltra, S; Falomir, E; Murga, J; Torijano-Gutiérrez, S; Vilanova, C | 1 |
| Diao, PC; Li, Q; Li, YH; Yang, HK; You, WW; Zhang, B; Zhao, PL | 1 |
| Bagul, C; Kamal, A; Lakshma Nayak, V; Shaik, SP; Shaik, TB; Srinivasa Reddy, T; Subba Rao, AV; Sunkari, S; Swapna, K | 1 |
| Abdelhafez, EMN; Abdelhamid, D; Aly, OM; Gamal-Eldeen, AM; Ibrahim, MAA; Mustafa, M | 1 |
| Abdelhafeez, DA; Aly, OM; Mustafa, M; Nofal, AE; Shatla, IM | 1 |
9 other study(ies) available for combretastatin and triazoles
| Article | Year |
|---|---|
Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Bibenzyls; Caspase 3; Cell Line, Tumor; Cell Shape; Cells, Cultured; Chick Embryo; Colchicine; Drug Screening Assays, Antitumor; Endothelial Cells; Enzyme Activation; G2 Phase; Humans; Membrane Potential, Mitochondrial; Mitochondria; Models, Molecular; Poly(ADP-ribose) Polymerases; Protein Binding; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Structure-Activity Relationship; Triazoles; Tubulin; Tubulin Modulators | 2010 |
Combretastatin A-4 and structurally related triazole analogues induce caspase-3 and reactive oxygen species-dependent cell death in PC12 cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Caspase 3; Caspase 9; Cell Death; PC12 Cells; Rats; Reactive Oxygen Species; Triazoles | 2013 |
Synthesis and antiproliferative activity of conformationally restricted 1,2,3-triazole analogues of combretastatins in the sea urchin embryo model and against human cancer cell lines.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bibenzyls; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Models, Animal; Molecular Conformation; Phenotype; Sea Urchins; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2014 |
Synthesis and biological evaluation of 1,2,3-triazole linked aminocombretastatin conjugates as mitochondrial mediated apoptosis inducers.
Topics: Antineoplastic Agents; Apoptosis; Bibenzyls; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; Hep G2 Cells; Humans; MCF-7 Cells; Mitochondria; Molecular Structure; Structure-Activity Relationship; Triazoles; Tubulin Modulators | 2014 |
Design and synthesis of pironetin analogue/combretastatin A-4 hybrids containing a 1,2,3-triazole ring and evaluation of their cytotoxic activity.
Topics: Antineoplastic Agents, Phytogenic; Bibenzyls; Cell Proliferation; Cells, Cultured; Drug Design; Drug Screening Assays, Antitumor; Flow Cytometry; HEK293 Cells; Humans; Molecular Structure; Neoplasms; Pyrones; Structure-Activity Relationship; Triazoles | 2014 |
Design, synthesis, and biological evaluation of novel alkylsulfanyl-1,2,4-triazoles as cis-restricted combretastatin A-4 analogues.
Topics: Antineoplastic Agents; Bibenzyls; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Neoplasms; Stereoisomerism; Structure-Activity Relationship; Triazoles | 2017 |
Synthesis and biological evaluation of cis-restricted triazole/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers.
Topics: Antineoplastic Agents; Apoptosis; Benzothiazoles; Bibenzyls; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Molecular Docking Simulation; Molecular Structure; Polymerization; Stereoisomerism; Structure-Activity Relationship; Tetrazoles; Triazoles; Tubulin | 2017 |
Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues.
Topics: Antineoplastic Agents; Bibenzyls; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Molecular Structure; Polymerization; Structure-Activity Relationship; Triazoles; Tubulin; Tubulin Modulators; Tumor Cells, Cultured | 2017 |
OMA1520 and OMA1774, novel 1,2,4-triazole bearing analogs of combretastatin A-4, inhibit hepatocellular carcinoma: Histological and immunohistochemical studies.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Carcinoma, Hepatocellular; Hep G2 Cells; HL-60 Cells; Humans; Liver Neoplasms, Experimental; Male; MCF-7 Cells; Molecular Docking Simulation; Rats; Triazoles | 2021 |